about
Cost effectiveness in low- and middle-income countries: a review of the debates surrounding decision rules.Equity of access to renal transplant waiting list and renal transplantation in Scotland: cohort study.Age as a criterion for setting priorities in health care? A survey of the German public viewPrioritising health service innovation investments using public preferences: a discrete choice experimentGuidance on priority setting in health care (GPS-Health): the inclusion of equity criteria not captured by cost-effectiveness analysisSocial and material deprivation and the cost-effectiveness of an intervention to promote physical activity: cohort study and Markov model.Improving the use of research evidence in guideline development: 12. Incorporating considerations of equity.Ethical issues in funding orphan drug research and development.The relevance of personal characteristics in allocating health care resources-controversial preferences of laypersons with different educational backgrounds.The prioritization preferences of pan-Canadian Oncology Drug Review members and the Canadian public: a stated-preferences comparisonUsing Cost-Effectiveness Analysis to Address Health Equity Concerns.Hidden costs: The ethics of cost-effectiveness analyses for health interventions in resource-limited settings.A note on the relative importance that people attach to different factors when setting priorities in health care.Lifetime QALY prioritarianism in priority setting: quantification of the inherent trade-offEquity versus efficiency: a dilemma for the NHS. If the NHS is serious about equity it must offer guidance when principles conflictAccounting for equity considerations in cost-effectiveness analysis: a systematic review of rotavirus vaccine in low- and middle-income countries.Systematic review of economic evaluations of interventions for high risk young people
P2860
Q33606843-907A0BD5-81CC-46A4-BD21-410F90C54101Q33821895-905B849E-9529-4526-B6FF-B65071EEB875Q34014462-7B1E5C23-D38E-41A2-B49D-98C89E602C1FQ34199406-1F4282FA-B8D9-4800-AF8E-6AE7B68413E2Q34224295-E2CDB5BA-3DCD-4609-9F90-8C7DBE7FDBCBQ34579559-25FDB1D0-864A-468E-8ED5-5ECED9F72BF2Q35225195-D1136ABD-8338-4DBF-A11D-31F8A7972FC5Q35429249-B4A1BC44-761D-48FC-930C-47B73BA047ECQ35859888-207D031B-61DC-4266-AF8A-5114B4597E3FQ37367877-EC592DB9-D075-4C30-9243-6152D29576EFQ37684773-B8AD9EB7-05E0-4809-9837-44021E9FB446Q40689362-308CC91F-1AED-48E1-9A5C-410504C54371Q41434344-0EFAB4E5-BECA-44C8-94ED-E2DD25CB8973Q41880782-0AA67C54-4907-4226-A64B-54199AE76C57Q42774092-36EA8DE3-AD37-406F-800D-7E1C36B61178Q55049262-9C4C07BF-349B-4867-A708-346096D97E75Q57167725-BC21DF41-8A27-4289-9007-4F96249F726A
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Equity and the economic evaluation of healthcare.
@ast
Equity and the economic evaluation of healthcare.
@en
Equity and the economic evaluation of healthcare.
@nl
type
label
Equity and the economic evaluation of healthcare.
@ast
Equity and the economic evaluation of healthcare.
@en
Equity and the economic evaluation of healthcare.
@nl
prefLabel
Equity and the economic evaluation of healthcare.
@ast
Equity and the economic evaluation of healthcare.
@en
Equity and the economic evaluation of healthcare.
@nl
P2093
P1476
Equity and the economic evaluation of healthcare.
@en
P2093
P577
2001-01-01T00:00:00Z